Best Grants for Teachers in Northern Mariana Islands

The NIA Academic Leadership Career Award (K07) provides funding for established investigators to strengthen research capacity in aging and Alzheimer's Disease. The program supports the development of educational infrastructure, mentorship, and career development activities. Key deadlines for applications include February 12, June 12, and October 12 from 2025 to 2027. This award is specifically for research not involving independent clinical trials, allowing applicants to gain experience in trials led by others.

The Preventing Violence Affecting Young Lives (PREVAYL 2.0) initiative aims to provide multiyear funding for state and local health departments to implement violence prevention strategies for adolescents and young adults. Key focuses include enhancing data-driven decision-making, building capacity for evidence-based strategies, integrating youth mental health support, fostering multisector collaborations, and prioritizing the prevention of various forms of violence, ensuring comprehensive support for youth development.

The NHLBI is set to release a NOFO aimed at enhancing an international research platform for cardiac surgery. This initiative will integrate various research areas, including mechanistic science and implementation science, to advance innovative techniques and improve health outcomes for adults with cardiovascular disease. Furthermore, the platform will serve to train future clinical trialists. Potential applicants are encouraged to start forming collaborations and preparing their proposals, as applications are not yet being solicited.

The NExT AI Hubs initiative by the NICHD aims to explore innovative applications of AI technologies in enhancing developmental outcomes for children at risk of learning disabilities. This program will focus on high-risk research topics, fostering advancements in understanding how AI can support learning in reading, writing, and mathematics. The initiative is backed by various public health laws, ensuring a comprehensive approach to child health and education.

The Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access program provides critical support to researchers by offering access to contract research organizations and subject matter experts. This funding opportunity aims to facilitate nonclinical therapeutic development efforts, helping investigators navigate the complexities of manufacturing and planning. Applications are due by 5:00 PM local time, with optional Letters of Intent recommended 30 days prior to the proposal deadline.

The Leukemia & Lymphoma Society's Equity in Access Research Grants aim to enhance equitable access to care for blood cancer patients and survivors. This program funds research to identify effective interventions that increase participation in clinical trials among underrepresented groups. Projects can receive up to $500,000 annually for a maximum of five years, with a total budget cap of $2.5 million. The initiative seeks to address systemic barriers that hinder clinical trial enrollment and improve healthcare access.

The BRAIN Initiative aims to support clinical studies that advance next-generation devices for recording and modulation in the human central nervous system. This initiative encourages small clinical trials to gather crucial data for developing devices that address central nervous system disorders. Investigators are invited to explore both Non-Significant and Significant Risk studies to enhance understanding of brain function, paving the way for future clinical trials and market approval.

The BRAIN Initiative invites proposals for innovative devices aimed at recording and modulating the human central nervous system. This program supports efforts in developing therapeutic and diagnostic devices through clinical prototype implementation, safety testing, and small clinical studies. The goal is to gather critical data on device functionality and design, which may not be achievable through traditional non-clinical studies. This initiative requires NIH collaboration in project planning and progress monitoring.

The NIA Postdoctoral Fellowship Award aims to enhance diversity in the translational research workforce for Alzheimer's disease and related dementias (AD/ADRD). This fellowship supports promising candidates from diverse backgrounds in developing essential translational research skills. The program emphasizes interdisciplinary approaches to treatment, prevention, and early detection of AD/ADRD while providing research experience under the guidance of mentors in clinical trials, fostering a diverse and effective research community.

The National Institute on Aging, in collaboration with the National Institute on Deafness and Other Communication Disorders, is announcing a Notice of Funding Opportunity (NOFO) aimed at exploring the link between olfactory decline and aging, Alzheimer's disease, and related dementias. This research could reveal olfactory dysfunction as a health indicator in older adults and identify new targets for therapeutic strategies. While applications are not currently being accepted, interested researchers are encouraged to prepare for future submissions.

The Advancing Equity Through Oral Health Funds, initiated by CareQuest Institute, seeks to transform oral health systems by supporting projects that dismantle disparities faced by marginalized communities. The program encourages organizations to propose innovative solutions that enhance access to dental care, engage community voices, and promote policies that ensure equitable health outcomes for all. This initiative aims to create a more integrated and accessible healthcare system, particularly for historically underserved populations.

The NIA Predoctoral Fellowship Award aims to enhance diversity in the translational research workforce focusing on Alzheimer's disease and related dementias. This funding opportunity supports promising predoctoral candidates from underrepresented backgrounds, fostering their research training and skills in various aspects of AD/ADRD. By encouraging interdisciplinary teamwork, the program seeks to develop a diverse workforce capable of contributing significantly to the prevention, treatment, and management of these conditions.

The NIH grant focuses on elucidating the role of transporters in key perinatal barriers such as the placenta and blood-brain barrier. By establishing a multi-barrier transport network, the initiative aims to enhance understanding of maternal and infant health regarding nutrient and medication transport. This research will create essential resources and standards, fostering future studies on perinatal exposure and intervention strategies. Ultimately, it aims to advance knowledge in pediatric pharmacology and neurodevelopment.

The Barbara A. Cooley Master’s Scholarship, offered by SHAPE America, is a $1,000 annual award for master's level students enrolled in accredited health education programs in the U.S. Recipients can use the funds as they wish and receive a complimentary one-year student membership with SHAPE America. The scholarship aims to support future educators and enhance the quality of health education, promoting research and professional practice in the field.

The NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) invites applications for mid-phase clinical trials involving natural products like botanicals and dietary supplements. The goal is to advance clinical testing through robust preliminary data, ensuring these products demonstrate measurable impacts on target engagement. Submission deadlines span from March 2024 to October 2026. Applications must focus on optimizing doses and identifying patient responders to inform future efficacy trials, aligning with NCCIH's research priorities.

The Bill Kane Undergraduate Scholarship, awarded by SHAPE America, provides $1,000 annually to undergraduate students majoring in school-based health education at accredited institutions in the U.S. or territories. Eligible candidates must be full-time students with a GPA of at least 3.25. Alongside the scholarship, recipients receive a complimentary one-year membership with SHAPE America, promoting professional development in health and physical education.

The NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) promotes innovative clinical trials on natural products, such as botanicals and dietary supplements. This funding opportunity supports studies that demonstrate significant scientific rationale and preliminary evidence for efficacy. Applications can explore various delivery methods and combinations with existing treatments to enhance outcomes. Funding is available for up to three years, aimed at bridging basic science discoveries into practical clinical applications.

The NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award supports investigator-initiated clinical trials of natural products, including botanicals and dietary supplements. This funding opportunity aims to validate the pharmacokinetics and bioavailability of these products over three years in a phased approach. Successful trials will provide crucial data for further development and clinical application, emphasizing the importance of scientifically driven research in natural product efficacy.

This funding opportunity aims to enhance the development of medical products in rare diseases through innovative natural history studies. By generating high-quality data, the FDA seeks to bridge critical knowledge gaps and eliminate barriers in rare disease research. The initiative focuses on diseases with unmet needs, fostering significant impacts for those affected and facilitating the development of effective therapeutic solutions.

The RFA-FD-23-001 funding opportunity aims to support clinical trials for orphan products targeting rare diseases. It focuses on evaluating the efficacy and safety of treatments to address unmet medical needs. By promoting innovative and collaborative trial designs, the FDA seeks to enhance the approval rates of effective therapies for rare conditions, ultimately benefiting patients and advancing drug development in this critical area.

The Health and Health Care Disparities grant aims to support innovative research that addresses the health challenges faced by individuals with disabilities, particularly in communities experiencing health disparities. Key application deadlines span from February 2024 to October 2026. This funding opportunity invites research proposals that explore the underlying factors affecting the health and well-being of these populations, promoting interventions that can lead to significant improvements in health equity.

The BJA FY 2026 Crisis Response Training Program aims to enhance public safety and law enforcement effectiveness by providing critical training for officers in responding to individuals experiencing behavioral health crises. This funding opportunity supports state, local, and tribal governments in developing programs to improve responses to those with mental health conditions, intellectual disabilities, and other challenges. By equipping officers with essential skills and strategies, the program seeks to ensure safer interventions and better outcomes in crisis situations.

The NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01) aims to support the career development of promising audiologists through rigorous postdoctoral research in biomedical, behavioral, or clinical sciences. This initiative encourages independent investigation in health-related research relevant to NIDCD's mission. Applications are due on various dates, with the next deadline on June 13, 2024, providing opportunities for advancing research in audiology and related fields.

The Tribal Undergraduate to Graduate Research Training and Leadership Experiences (TURTLE) Program aims to foster the development of American Indian and Alaska Native scientists by funding eligible Tribal Entities. This initiative focuses on creating effective training and mentoring activities for individuals pursuing doctoral degrees in biomedical research. Ultimately, it seeks to enhance the capability of researchers to address health disparities within AI/AN communities, ensuring culturally appropriate and ethically responsible research practices.

The Intervention Research to Improve Native American Health (R21 Clinical Trials Optional) aims to support exploratory studies focused on enhancing health outcomes within Native American populations. This initiative encourages research that addresses critical health disparities, tests new interventions, and develops culturally appropriate solutions to improve health and well-being. Applications are encouraged to include community-driven research, addressing unique sociopolitical and environmental challenges faced by these populations, ultimately aiming to reduce morbidity and mortality.

The NIDCD Mentored Career Development Award supports postdoctoral Au.D./Ph.D. audiologists in their research and career development. This grant aims to foster independence in scientific health-related research relevant to the NIDCD's mission. Key deadlines for applications span from June 2024 to May 2027, providing numerous opportunities for eligible candidates to secure funding and advance their careers in the biomedical and clinical sciences.

This funding opportunity announcement aims to enhance health interventions for Native American populations. It supports research to develop, adapt, and test culturally informed health promotion and disease prevention strategies. The initiative addresses significant health disparities faced by these communities, emphasizing sustainable and adaptable solutions. Researchers are encouraged to build on community strengths and resilience, focusing on effective dissemination and integration of interventions. The program welcomes applications targeting diverse Native American groups, including Alaska Natives and Native Hawaiians.